Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 3
1982 1
1983 3
1984 4
1985 10
1986 7
1987 5
1988 9
1989 4
1990 13
1991 5
1992 4
1993 3
1994 5
1995 5
1996 6
1997 7
1998 8
1999 8
2000 11
2001 17
2002 8
2003 7
2004 7
2005 9
2006 14
2007 11
2008 9
2009 8
2010 11
2011 19
2012 14
2013 11
2014 18
2015 17
2016 19
2017 16
2018 10
2019 10
2020 11
2021 11
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

363 results
Results by year
Filters applied: . Clear all
Page 1
[Skin aging: Pathophysiology and innovative therapies].
Boismal F, Serror K, Dobos G, Zuelgaray E, Bensussan A, Michel L. Boismal F, et al. Among authors: bensussan a. Med Sci (Paris). 2020 Dec;36(12):1163-1172. doi: 10.1051/medsci/2020232. Epub 2020 Dec 9. Med Sci (Paris). 2020. PMID: 33296633 Free article. Review. French.
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
Perrot I, Michaud HA, Giraudon-Paoli M, Augier S, Docquier A, Gros L, Courtois R, Déjou C, Jecko D, Becquart O, Rispaud-Blanc H, Gauthier L, Rossi B, Chanteux S, Gourdin N, Amigues B, Roussel A, Bensussan A, Eliaou JF, Bastid J, Romagné F, Morel Y, Narni-Mancinelli E, Vivier E, Paturel C, Bonnefoy N. Perrot I, et al. Among authors: bensussan a. Cell Rep. 2019 May 21;27(8):2411-2425.e9. doi: 10.1016/j.celrep.2019.04.091. Cell Rep. 2019. PMID: 31116985 Free article.
ENTPD1/CD39 is a promising therapeutic target in oncology.
Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF, Bensussan A. Bastid J, et al. Among authors: bensussan a. Oncogene. 2013 Apr 4;32(14):1743-51. doi: 10.1038/onc.2012.269. Epub 2012 Jul 2. Oncogene. 2013. PMID: 22751118 Review.
CD160: a unique activating NK cell receptor.
Le Bouteiller P, Tabiasco J, Polgar B, Kozma N, Giustiniani J, Siewiera J, Berrebi A, Aguerre-Girr M, Bensussan A, Jabrane-Ferrat N. Le Bouteiller P, et al. Among authors: bensussan a. Immunol Lett. 2011 Aug 30;138(2):93-6. doi: 10.1016/j.imlet.2011.02.003. Epub 2011 Feb 13. Immunol Lett. 2011. PMID: 21324341 Review.
Clinical Translation and Evaluation of a Handheld and Biocompatible Mass Spectrometry Probe for Surgical Use.
Zhang J, Sans M, DeHoog RJ, Garza KY, King ME, Feider CL, Bensussan A, Keating MF, Lin JQ, Povilaitis SC, Katta N, Milner TE, Yu W, Nagi C, Dhingra S, Pirko C, Brahmbhatt KA, Van Buren G, Carter S, Thompson A, Grogan RH, Suliburk J, Eberlin LS. Zhang J, et al. Among authors: bensussan a. Clin Chem. 2021 Sep 1;67(9):1271-1280. doi: 10.1093/clinchem/hvab098. Clin Chem. 2021. PMID: 34263289
CD100 is a leukocyte semaphorin.
Delaire S, Elhabazi A, Bensussan A, Boumsell L. Delaire S, et al. Among authors: bensussan a. Cell Mol Life Sci. 1998 Nov;54(11):1265-76. doi: 10.1007/s000180050252. Cell Mol Life Sci. 1998. PMID: 9849618 Review.
[IKDC: a new suit for active NK cells].
Coulombel L, Bensussan A. Coulombel L, et al. Among authors: bensussan a. Med Sci (Paris). 2008 May;24(5):521-4. doi: 10.1051/medsci/2008245521. Med Sci (Paris). 2008. PMID: 18466730 Free article. Review. French. No abstract available.
363 results